Zhejiang-based SprintRay Co., a one-stop digital chair side solution provider for dental institutions, has reportedly raised over USD 100 million in a Series D financing round. The round was led by SoftBank Vision Fund 2, with contributions from Yiheng Capital and ZWC Partners, alongside existing investors CDBI Partners and Marathon Venture Partners. This follows the company’s previous Series C+ financing round in April 2021, which raised “tens of millions” of renminbi, solely led by Shunwei Capital.
Company Background and Market Position
Founded in 2013, SprintRay has achieved a 50% market share in the chair side dental 3D printing field in the US, with an impressive 80% five-year compound growth rate. The company’s product pipeline includes a comprehensive suite of solutions, such as the SprintRay Pro S 3D printer, resin material, dental 3D printing software, Pro Wash/Dry, ProCure 2, digital design service, and the Dashboard 2.0 medical technology interaction platform. SprintRay also maintains teams in China, the US, and Europe.
Global Market Outlook
Statistics indicate that the global dental 3D printing market was valued at USD 3.5 billion in 2021, with projections reaching USD 6.6 billion by 2026, growing at a compound annual growth rate of 15%. This rapid expansion underscores the significant potential for SprintRay’s innovative solutions in the dental industry.
Future Outlook
The Series D financing round highlights SprintRay’s commitment to advancing digital dental solutions. By leveraging the new funds, the company aims to enhance its product offerings, expand its market presence, and continue driving innovation in dental 3D printing.-Fineline Info & Tech
